The potential benefit of scaling up malaria prevention to reduce low birth weight in Africa

1. Guyatt H.L. and Snow R.W., Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev, 2004. 17(4): p. 760–9. doi: 10.1128/CMR.17.4.760-769.2004 15489346

2. Walker P.G.T., et al., Estimated Impact on Birth Weight of Scaling- up Intermittent Preventive Treatment for Malaria in Pregnancy Given Sulphadoxine-Pyrimethamine Resistance in Africa: a Mathematical Model. PLoS Med. 2017;14(2): e1002243. doi: 10.1371/journal.pmed.1002243

3. Radeva-Petrova D., et al., Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment. Cochrane Database Syst Rev, 2014(10): p. CD000169. doi: 10.1002/14651858.CD000169.pub3 25300703

4. WHO, Methods and techniques for assessing exposure to antimalarial drugs in clinical field studies, 2011, World Health Organisation: Geneva.

5. WHO, A strategic framework for malaria prevention and control during pregnancy in the Africa region, 2004: Brazzaville: World Health Organization Regional Office for Africa.

6. Chico R.M., et al., Global Call to Action: maximize the public health impact of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa. Malar J, 2015. 14: p. 207. doi: 10.1186/s12936-015-0728-x 25986063

7. Harrington W.E., et al., Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci U S A, 2009. 106(22): p. 9027–32. doi: 10.1073/pnas.0901415106 19451638

8. Dicko A., et al., Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial. PLoS Med, 2011. 8(2): p. e1000407. doi: 10.1371/journal.pmed.1000407 21304923

9. White N.J., Intermittent presumptive treatment for malaria. PLoS Med, 2005. 2(1): p. e3. doi: 10.1371/journal.pmed.0020003 15696210

10. Taylor S.M., et al., Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study. Clin Infect Dis, 2012. 55(1): p. 42–50. doi: 10.1093/cid/cis301 22441649

11. Kakuru A., et al., Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy. N Engl J Med, 2016. 374(10): p. 928–39. doi: 10.1056/NEJMoa1509150 26962728

12. Desai M., et al., Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial. Lancet, 2015. 386(10012): p. 2507–19. doi: 10.1016/S0140-6736(15)00310-4 26429700

13. Madanitsa M., et al., Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial. PLoS Med, 2016. 13(9): p. e1002124. doi: 10.1371/journal.pmed.1002124 27622558

14. van Eijk A.M., et al., Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009–11. Lancet Infect Dis, 2013. 13(12): p. 1029–42. doi: 10.1016/S1473-3099(13)70199-3 24054085

15. Hill J., et al., Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med, 2013. 10(7): p. e1001488. doi: 10.1371/journal.pmed.1001488 23935459

16. Wallace A.S., Ryman T.K., and Dietz V., Experiences integrating delivery of maternal and child health services with childhood immunization programs: systematic review update. J Infect Dis, 2012. 205 Suppl 1: p. S6–19.